Completed EARLY_PHASE1 INTERVENTIONAL 2-arm NCT05592041

Studying of Natural Constituents' Treatment of Plantar Warts

In-vitro and Randomized Controlled Clinical Studying of Natural Constituents' Anti-HPV Potential for Treatment of Plantar Warts Supported With in Silico Studies

Sponsor: Deraya University

Conditions Plantar Wart

Interventions Banaba Leaf Extract

Updated 5 times since 2022 Last updated: May 15, 2024 Started: Oct 20, 2022 Primary completion: Dec 18, 2022 Completion: Jan 10, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05592041, this EARLY_PHASE1 trial focuses on Plantar Wart and remains completed. Sponsored by Deraya University, it has been updated 5 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Jun 2024 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Feb 2023 — Jun 2024 [monthly]

Completed EARLY_PHASE1

Status: Recruiting → Completed
Nov 2022 — Feb 2023 [monthly]

Recruiting EARLY_PHASE1

First recorded

Oct 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Deraya University

Data source: Deraya University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Minya, Egypt